SAB Biotherapeutics(SABS)
$3.00+0.04 (+1.35%)
SABS
SAB Biotherapeutics earnings date
$3.00
At close:+0.04 (+1.35%)
Want to see SABS full AI Analyst Report?
SAB Biotherapeutics (SABS) Q2 2026 Earnings Report
332 Followers
SABS Q2 2026 EPS Results
- Actual EPS
- -$0.28
- Consensus EPS
- -$0.29
- Beat/Miss
- Beat by +$0.01
- One Year Ago EPS
- -$1.09
SABS Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
SABS Upcoming Earnings
SAB Biotherapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
SABS Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
SABS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -0.24- | -0.35 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.28-0.24 | -0.21 | -14.29% (-0.03) | |
| Aug 06, 2026 | 2026 (Q2) | -0.29-0.28 | -1.09 | 74.31% (+0.81) | |
| May 12, 2026 | 2026 (Q1) | -0.21-0.35 | -0.56 | 37.50% (+0.21) | |
| Mar 26, 2026 | 2025 (Q4) | -0.21-0.27 | -1.23 | 78.05% (+0.96) | |
| Nov 13, 2025 | 2025 (Q3) | -0.46-0.21 | -1.12 | 81.25% (+0.91) | |
| Aug 07, 2025 | 2025 (Q2) | -0.80-1.09 | -0.79 | -37.97% (-0.30) | |
| May 09, 2025 | 2025 (Q1) | ―- | -0.54 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -1.07-0.56 | -0.54 | -3.70% (-0.02) | |
| Nov 06, 2024 | 2024 (Q3) | -1.11-1.12 | -1 | -12.00% (-0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

